← Back to Search

Omega-3 Fatty Acid Supplement

EPA/DHA Supplements for Healthy Eating

Phase < 1
Recruiting
Led By Yael Vodovotz, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will study if an algae oil-fortified soymilk is as effective as a commercial algae oil capsule in increasing EPA and DHA in the blood.

Who is the study for?
This trial is for adults with a BMI between 18 and 30 who are not pregnant or nursing, don't have anemia, high cholesterol/triglycerides, coagulation disorders, diabetes, allergies to ingredients in the test products, and haven't taken omega-3 supplements or certain medications recently.Check my eligibility
What is being tested?
The study aims to compare how well the body absorbs EPA and DHA (healthy fats) from algae oil fortified soymilk versus standard algae oil capsules. It will measure the levels of these fats in participants' blood over time.See study design
What are the potential side effects?
Since this trial involves healthy eating interventions with soymilk and capsules containing natural oils, side effects might be minimal but could include digestive discomfort or allergic reactions if sensitivity to ingredients exists.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Erythrocyte EPA and DHA levels
Secondary outcome measures
Peripheral blood mononuclear cell (PBMC) EPA and DHA levels
Plasma EPA and DHA levels
Other outcome measures
Compliance

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Algae Oil Fortified SoymilkExperimental Treatment1 Intervention
Subjects will drink 12 ounces of 0.4% algae oil-fortified soymilk
Group II: Algae Oil SupplementsActive Control1 Intervention
Subjects will take 2 commercial algae oil capsules.

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,143 Total Patients Enrolled
Yael Vodovotz, PhDPrincipal InvestigatorOhio State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research study involve participants of advanced age?

"The clinical trial set out to enrol participants between ages 18 and 60. For those under 18, there is a separate study with 16 available spots; for individuals over 65, 43 places are accessible in another evaluation."

Answered by AI

How many participants has the research team recruited for this trial?

"Affirmative. According to the information available on clinicaltrials.gov, this medical research is presently enrolling participants; it was first posted on April 3rd 2023 and last updated a day later. The trial requires 24 volunteers from 1 particular site for participation."

Answered by AI

Are there any vacancies available for prospective participants of this research?

"Affirmative. Clinicaltrials.gov suggests that this clinical trial, which was first posted on April 3rd 2023, is actively seeking participants. A total of 24 people must be recruited from one centre for the study to take place."

Answered by AI

May I enroll in this trial?

"Candidates seeking to partake in this clinical trial should maintain a healthy lifestyle and be aged between 18-60. The total number of enrollees for the study is expected to reach 24 participants."

Answered by AI
~3 spots leftby Jul 2024